Iosat 130 MG tablet 14S
Ended Awarded Last action
- Contract number
- SPE2DR26FJGP3
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,290
Award facts
- Contract value 100% obligated
- $11,289.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,289.60 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for IOSAT 130 mg tablets (14-count packages). The delivery order, issued on December 18, 2025, with an ultimate completion date of December 19, 2025, carries no set-aside designation, indicating the award was made through open competition. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.999 billion contract awarded on November 13, 2025, that positions the company as a critical regional pharmaceutical supplier for Department of Defense medical operations.
The PPV-G GEN V represents a comprehensive $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors that supply a full spectrum of pharmaceutical products—including branded and generic prescription medications, biologics, vaccines, and medical consumables—to military healthcare facilities worldwide. DMS Pharmaceutical Group's selection as a prime vendor contractor reflects its demonstrated federal contracting capability and consistent performance across diverse therapeutic categories. The company has executed numerous delivery orders since October 2025, ranging from small purchases under $100 to significant awards exceeding $115,000, establishing its operational readiness to fulfill the specialized pharmaceutical requirements of the military medical system with no identified subcontractor relationships.
Quick answers
Who was awarded contract SPE2DR26FJGP3?
SPE2DR26FJGP3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 18, 2025.
How much is contract SPE2DR26FJGP3 worth?
The government has obligated $11,290 on SPE2DR26FJGP3.
Is contract SPE2DR26FJGP3 an order under another contract?
Yes. SPE2DR26FJGP3 is a delivery order under SPE2DR25D9150, an indefinite delivery contract.
Was contract SPE2DR26FJGP3 competed?
The extent of competition for SPE2DR26FJGP3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award